Singh, S., Quarni, W., Goralski, M., Wan, S., Jin, H., Van de Velde, L.-A., Fang, J., Wu, Q., Abu-Zaid, A., Wang, T., Singh,
R., Craft, D., Fan, Y., Confer, T., Johnson, M., Akers, W. J., Wang, R., Murray, P. J., Thomas, P. G., Nijhawan, D., Davidoff,
A. M., & Yang, J. (2021). Targeting the spliceosome through RBM39 degradation results
in exceptional responses in high-risk neuroblastoma models. Science Advances, 7(47):.
doi:10.1126/sciadv.abj5405.